Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Venture Partners
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Venture Partners
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2026-10-30
Next Day Disclosure Return
2026-10-27
Next Day Disclosure Return
2026-10-23
INSIDE INFORMATION ANNOUNCEMENT - NMPA APPROVAL OF BATOCLIMAB INJECTION (SUBCUTANEOUS INJECTION) FOR THE TREATMENT OF GENERALIZED MYASTHENIA GRAVIS
2026-10-20
Next Day Disclosure Return
2026-10-16
Next Day Disclosure Return
2026-10-15
Next Day Disclosure Return
2026-10-14
Next Day Disclosure Return
2026-10-13
Next Day Disclosure Return
2026-10-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
2026-09-21
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2025 ANNUAL REPORT AND THE 2026 INTERIM REPORT
2026-09-16
VOLUNTARY ANNOUNCEMENT - NONA BIOSCIENCES DEVELOPS THE WORLD'S FIRST LANGUAGE MODEL TRAINED ON FULLY HUMAN HEAVY-CHAIN-ONLY ANTIBODIES
2026-09-10
Interim Report 2026
2026-09-09
VOLUNTARY ANNOUNCEMENT - IN RELATION TO SERIES A FINANCING OF THE COMPANY'S PARTNER SOLSTICE ONCOLOGY
2026-09-08
VOLUNTARY ANNOUNCEMENT - POSITIVE PHASE II INTERIM RESULTS AND INITIATION OF PHASE III STUDY OF HBM9378/WIN378 IN ASTHMA
2026-09-07
VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT
2026-09-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026
2026-09-02
SUPPLEMENTAL ANNOUNCEMENT - RESIGNATION OF EXECUTIVE DIRECTOR; APPOINTMENT OF EXECUTIVE DIRECTORS; AND CHANGE OF AUTHORIZED REPRESENTATIVE
2026-08-27
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2026-08-27
RESIGNATION OF EXECUTIVE DIRECTOR; APPOINTMENT OF EXECUTIVE DIRECTORS; AND CHANGE OF AUTHORIZED REPRESENTATIVE
2026-08-27
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026
1
2
3
···
22
Jump
